SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

RenovaCare, Inc. (RCAR)

RCAR RSS Feed 		Add RCAR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/15/2017 5:03:16 PM - Followers: 11 - Board type: Free - Posts Today: 0

RenovaCare, Inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs.

Our initial products under development target the body’s largest organ, the skin. Our flagship technology, the CellMist™ System, uses our patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. We’re also developing medical-grade liquid spray devices for wound care and irrigation fluids.

In investigative clinical use in the United States, SkinGun™ treatments have shown the potential to naturally and rapidly heal burns and other serious wounds.

We are developing our CellMist™ System as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars. In the US alone, this $45 billion market is greater than spending on high-blood pressure management, cholesterol treatments, and back pain therapeutics.

Currently in investigational clinical use for second degree burn patients in the United States, our CellMist™ System targets an estimated 143 million patients worldwide who suffer burns, chronic and acute wounds, acne scarring, and skin defects and diseases such as vitiligo (a skin discoloration condition, suffered by celebrities Michael Jackson and Jon Hamm). According to the National Institutes of Health, skin disorders account for 40% of occupational-disease claims nationally.

For patients the potential breakthrough of a quick-healing, gentle mist of their own stem cells will be a promising alternative to conventional skin grafts, which can be extremely painful, slow-to-heal, and prone to complications.

The CellMist™ System harvests a patient’s stem cells from a small area of skin, generally around 1 square inch, and suspends them in the water-based CellMist™ Solution. The suspension is delicately sprayed onto the wound using the SkinGun™ deposition device, where it begins to grow new skin at the cellular level.

RenovaCare’s SkinGun™ spray device is the world’s most advanced technology of its kind, using a gentle positive-pressure air stream to spray the CellMist™ Solution onto wounds. This is a marked improvement over pump spray devices, which spray by creating high pressure behind a narrow aperture, and expose fragile cells to strong forces that are likely to tear them apart. This procedure can take as little as 90 minutes from start to finish. In some cases patients will be able to leave the hospital within only a few days, rather than the many weeks required by other alternative treatments such as in-vitro cultured epithelial grafts.

RenovaCare, Inc.
430 Park Avenue
Suite 702
New York, NY 10022
United States
Phone: 800-755-5815
Website: http://www.renovacareinc.com



RenovaCare, Inc. Completes Engineering, Research, and Studies Required to File 510(k) Submission to the FDA for its Novel Medical-Grade Liquid Spray Device
https://finance.yahoo.com/news/renovacare-inc-completes-engineering-research-131500120.html

New Study: RenovaCare SkinGun™ Ultra-Gently Sprays Human Stem Cells to Achieve ‘Gold-Standard’ Viability for Skin Regeneration
http://www.businesswire.com/news/home/20160503005131/en/Study-RenovaCare-SkinGun™-Ultra-Gently-Sprays-Human-Stem

RenovaCare Awarded U.S. Patent For SkinGun™ Device To Spray Stem Cells On To Wounds
http://www.businesswire.com/news/home/20161206005236/en/RenovaCare-Awarded-U.S.-Patent-SkinGun™-Device-Spray

RenovaCare: 2017 Shareholder Update
https://finance.yahoo.com/news/renovacare-2017-shareholder-141500267.html

SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
RCAR
Current Price
Volume:
Bid Ask Day's Range
RCAR Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
RCAR News: Quarterly Report (10-q) 08/14/2017 11:36:32 AM
RCAR News: Current Report Filing (8-k) 07/24/2017 02:11:16 PM
RCAR News: Notice of Effectiveness (effect) 07/07/2017 06:01:45 AM
RCAR News: Securities Registration Statement (s-1/a) 06/06/2017 01:49:57 PM
RCAR News: Notice of Effectiveness (effect) 05/18/2017 06:02:25 AM
PostSubject
#96   Are these the patents in question? shaidetrade 08/15/17 05:03:16 PM
#95   $RCAR is trading strong today! Good news may bybtrader 08/10/17 01:02:40 PM
#94   RCAR patent has been challenged at the USPTO Notbelievingit 07/07/17 09:44:06 PM
#93   Wrong HumanTyphoon 05/27/17 12:45:11 PM
#92   Renovacare has not started a clinical trial. jason_luke 05/21/17 09:26:53 PM
#91   jason_luke is one of them HumanTyphoon 05/21/17 06:44:31 PM
#90   Watch out for investors from Avita. They are HumanTyphoon 05/21/17 06:42:43 PM
#89   I tried contacting Renovacare several times to no inversor86 05/20/17 04:32:00 AM
#88   They also conducted the trial at the actual inversor86 05/20/17 04:25:17 AM
#87   Lol inversor86 05/20/17 04:23:51 AM
#86   FACT: Renovacare is doing an equity raise and jason_luke 05/19/17 05:15:04 PM
#85   This bloated equity is in some serious trouble. jason_luke 05/19/17 05:08:32 PM
#84   RENOVACARE is the REAL deal thenurse 05/19/17 04:01:27 PM
#83   RENOVACARE is the REAL deal thenurse 05/19/17 03:52:18 PM
#82   I am. I know the space, I've inversor86 05/18/17 12:52:49 PM
#81   I'm sure you would, considering you're an investor ihubmkasp 05/18/17 12:30:35 PM
#80   Wow. I don't feel bad for people inversor86 05/18/17 08:34:57 AM
#79   Harmel Rayat and his family-owned Kalen Capital own jason_luke 05/16/17 06:57:05 PM
#78   I believe that RenovaCare is a company of inversor86 05/16/17 02:13:51 PM
#77   From Renovacare S-3: jason_luke 05/16/17 12:17:03 PM
#76   That's the last time I trust you. HumanTyphoon 05/14/17 09:15:00 PM
#75   They are not being sued. Avita claim that HumanTyphoon 05/14/17 09:14:39 PM
#74   Thank you HumanTyphoon 05/14/17 09:01:16 PM
#73   Lawsuit Against Renovacare hey boys, just wanna let jason_luke 05/11/17 12:56:15 PM
#72   https://www.insiderfinancial.com/renovacare-inc-otcmktsrcar-is-a-sleeping-giant/ guatdodger 05/11/17 09:59:58 AM
#71   RCAR bullish 4.10 stocktrademan 05/04/17 03:16:58 PM
#70   If we only knew how long FDA approval pavah 04/30/17 06:28:50 PM
#69   This stock is going to be huge pretty soon! http://www.businesswire.com/news/ho bybtrader 04/27/17 10:24:01 AM
#68   We need to be patient. They have go_glortho 04/11/17 11:48:40 PM
#67   Looks like this is going to be featured ASA454 04/11/17 03:36:50 PM
#66   Its amazing to me this is sooo low. HumanTyphoon 03/29/17 09:01:42 PM
#65   Until something else actually happens with this product, ihubmkasp 02/23/17 09:56:53 AM
#64   Might buy some under $2.50 willlbone 02/22/17 02:13:46 PM
#63   But it is getting better... misiu143 02/22/17 01:29:50 PM
#62   Big dip trickledownfacists 02/22/17 01:14:18 PM
#61   We have our dip now !!! misiu143 02/22/17 12:56:28 PM
#60   Hahaha, yes I bet you are!! If I remember goldenisla 02/21/17 10:20:47 AM
#59   In at $3.33, very pleased! Triple9 02/21/17 10:13:05 AM
#58   I looked into this stock a few weeks goldenisla 02/21/17 10:10:47 AM
#57   Can you share the report or the link bybtrader 02/17/17 12:24:45 PM
#56   A research report was issued on the stock Vette661 02/17/17 10:49:29 AM
#55   A research report was issued on the stock Vette661 02/17/17 10:48:52 AM
#54   I'm getting the float information from OTC website. bybtrader 02/16/17 11:57:18 PM
#53   Ah yeah... I was thinking there was a cwhockey31 02/16/17 11:50:44 PM
#52   The reason is simple. First of all RCAR bybtrader 02/16/17 11:48:16 PM
#51   But why the surge in price now? I cwhockey31 02/16/17 10:45:52 PM
#50   IMO $RCAR will soon see way higher PPS bybtrader 02/16/17 11:54:50 AM
#49   I was doing other things so I missed Triple9 02/16/17 10:49:25 AM
#48   Agreed. misiu143 02/16/17 10:04:35 AM
#47   No idea but something is going on lol Triple9 02/16/17 10:03:43 AM
PostSubject
© 2017 InvestorsHub.Com, Inc.